Funding

NIH - 5R33AG069794

Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in Elderly with Alzheimer's Disease Study (D-PRESCRIBE-AD)

Funder: National Institutes of Health

PI: Jerry Gurwitz, University of Massachussetts

Period of Performance: September 30, 2020 - August 31, 2025

Objectives

During the R33 phase we will sequentially implement two separate pragmatic trials, each enrolling over 11,000 patients, adapting the second trial based on the findings and experience gained in the first. The R33 aims are: (1) to assess the impact of the patient/caregiver educational intervention on inappropriate prescribing to AD/ADRD patients, employing a prospective, cluster randomized trial design with three arms; and (2) to create a plan for disseminating study findings to stakeholders who might implement the intervention or make decisions about its future use.

Supported Publications that Include Dr. Parlett

Disclaimer

The content of this website, including articles, papers, and any other materials, reflects my personal views and opinions. They do not necessarily represent the views or opinions of my employer, colleagues, or any affiliated organizations. Unless explicitly stated otherwise, this content was generated without the use of any generative AI or large language models (LLMs); all information presented here is solely the result of human input and research.

I may provide links to external websites for convenience or reference, but this does not constitute an endorsement of those sites or the content within them. I am not responsible for the content, accuracy, or reliability of any external websites.

All information shared on this website is for informational purposes only and should not be construed as professional advice.

2024 Lauren Elizabeth Parlett, PhD - Epidemiologist. All rights reserved.

site admin | credits